Excerpt from “Toward HIV Treatment on Demand for All: Closing the Gap Between Science and Policy.” Health GAP Global Policy Analysis. December 2015.
High price of newer, improved medicines: While the price of many antiretroviral medicines has decreased significantly over the past 15 years, trade and intellectual property rights barriers inhibit affordable access to newer, more effective medicines. Side effects of many antiretroviral medicines can be a hindrance in adhering to treatment and starting treatment early may exacerbate this challenge. Combination regimens containing the least toxic and most effective medicines are unavailable in many countries due to their higher cost. This problem is especially acute in middle-income countries, which are excluded from voluntary licenses and price discounts. Overcoming patent and other IP monopolies and driving down the cost of medicines through robust generic competition is urgently needed.
Click here for the full report (PDF).
QUT Media4th November 2025 The United Kingdom Parliament is considering a bill aimed at making smoking obsolete, which has been
Speaking at the Global Expert Network on Copyright User Rights Symposium on 16 June 2025, Professor Christophe Geiger argues for
On 25 September 2025, Professor Wend Wendland, delivered the 14th Peter Jaszi Distinguished Lecture at American University in Washington D.C..
On September 18, 2025, the Italian Senate definitively approved the country’s first comprehensive framework law on artificial intelligence (AI). The
Por Andrés Izquierdo Durante la segunda semana de agosto, fui invitado a hablar en la Feria Internacional del Libro de
By Andrés Izquierdo AI, Copyright, and the Future of Creativity: Notes from the Panama International Book FairDuring the second week